Individuals Coming Off Anti-Obesity Jabs Regain Weight at a Quadrupled Rate Than People Using Diet and Exercise

New research suggests that patients who come off popular weight-loss injections like semaglutide or tirzepatide tend to recover shed pounds far faster than those who stop conventional diet and exercise regimens.

Published data in a prominent medical journal shows that while obese individuals often shed a large proportion of their body weight while undergoing treatment, the weight is regained at an estimated rate of 0.8 kg per month upon discontinuation.

"Users purchasing such medications need to be aware of the risk of rapid weight regain when the treatment ends," stated expert Dr. Susan Jebb.

That rate of recovery means a reversion to starting mass within about a year and a half.

Weighing Therapies

The research, which examined dozens of trials involving thousands of participants, contrasted the results of GLP-1 agonists with older methods.

Researchers emphasize that people who shed pounds through diet and exercise generally see a slower weight regain—perhaps 0.1 kg a month—once they finish.

The Reason for the Fast Rebound

Experts suggest the mode of action of the jabs is key to understanding the heightened weight return.

These medications imitate a body's own chemical called GLP-1, which helps regulate hunger.

"Artificially providing GLP-1 levels far above than normal might result in the system to generate a reduced amount of its endogenous GLP-1, and may also lessen responsiveness to its actions," said Dr. Adam Collins, a nutrition specialist.

"Stopping of this hormone supplement results in hunger is uncontrolled, making binge eating much more probable."

A Chronic Condition?

Health authorities advise the injections for individuals with obesity-related medical conditions, alongside recommended diet and exercise modifications.

Many experts say that, due to the significant potential of relapse, the therapy should be considered long-term.

This opinion is supported by pharmaceutical companies, who say that the results "underscore the long-term nature of obesity," akin to managing conditions like high blood pressure.

User Accounts

Individuals who have come off the medication explain a intense return of hunger.

"It felt as if something flipping and I was suddenly extremely hungry," said an individual.

This challenge is worsened if patients have not established sustainable lifestyle or habit changes during treatment.

Significant Interest

Recent estimates indicate that millions of adults in the UK have tried weight-loss jabs in the last 12 months, with demand continuing to grow.

• Use is more common among women than males.
• The middle-aged age group shows the highest level of interest.
• Many obtain the medications through private prescriptions rather than public health services.

In conclusion, clinicians emphasize that while the jabs are powerful agents for shedding pounds, they are not a standalone fix and lasting health benefits likely depends on integrated behavioural management.